Correlation Between Enanta Pharmaceuticals and Scilex Holding

Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Scilex Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Scilex Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enanta Pharmaceuticals and Scilex Holding, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Scilex Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Scilex Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Scilex Holding.

Diversification Opportunities for Enanta Pharmaceuticals and Scilex Holding

-0.7

Correlation Coefficient

Enanta Pharmaceuticals  Scilex Holding

Excellent diversification

The 3 months correlation between Enanta and Scilex is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Scilex Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scilex Holding and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Scilex Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scilex Holding has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Scilex Holding go up and down completely randomly.

Pair Corralation between Enanta Pharmaceuticals and Scilex Holding

Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 0.96 times more return on investment than Scilex Holding. However, Enanta Pharmaceuticals is 1.04 times less risky than Scilex Holding. It trades about 0.02 of its potential returns per unit of risk. Scilex Holding is currently generating about -0.12 per unit of risk. If you would invest  600.00  in Enanta Pharmaceuticals on December 26, 2024 and sell it today you would lose (12.00) from holding Enanta Pharmaceuticals or give up 2.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Enanta Pharmaceuticals  vs.  Scilex Holding

Enanta Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Enanta Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Enanta Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Scilex Holding

Risk-Adjusted Performance

Very Weak

Over the last 90 days Scilex Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Enanta Pharmaceuticals and Scilex Holding

The main advantage of trading using opposite Enanta Pharmaceuticals and Scilex Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Scilex Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scilex Holding will offset losses from the drop in Scilex Holding's long position.

The idea behind Enanta Pharmaceuticals and Scilex Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.